Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaili Zhao

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Appetite|May 13, 2022
Does a beautiful environment make food better - The effect of environmental aesthetics on food perception and eating intentionChenjing Wu, Hongyan Zhu, Chuangbing Huang, et al.
ACS Applied Materials & Interfaces|November 22, 2024
Dual-Targeted Assembled Nanodrugs for Near-Infrared Photothermal Immunotherapy of Triple-Negative Breast CancerKaili Zhao, Guizhi Shen, Yamei Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 3, 2018
Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signalingWei Wang, Lingling Wu, Qing Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 12, 2026
Betulinic acid induces lysosome-dependent death in prostate cancer by targeting DDX5Shoushi Liu, Xiaolan Li, Zhiping Cheng, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Gut|February 24, 2023
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradationJing Liu, Weiwei Bai, Tianxing Zhou, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Appetite|May 13, 2022
Does a beautiful environment make food better - The effect of environmental aesthetics on food perception and eating intentionChenjing Wu, Hongyan Zhu, Chuangbing Huang, et al.
ACS Applied Materials & Interfaces|November 22, 2024
Dual-Targeted Assembled Nanodrugs for Near-Infrared Photothermal Immunotherapy of Triple-Negative Breast CancerKaili Zhao, Guizhi Shen, Yamei Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 3, 2018
Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signalingWei Wang, Lingling Wu, Qing Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 12, 2026
Betulinic acid induces lysosome-dependent death in prostate cancer by targeting DDX5Shoushi Liu, Xiaolan Li, Zhiping Cheng, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Gut|February 24, 2023
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradationJing Liu, Weiwei Bai, Tianxing Zhou, et al.
Pageof 3